{"product_id":"medicalpropertiestrust-bcg-matrix","title":"MPT Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock Strategic Clarity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe MPT BCG Matrix snapshot shows how products map across market growth and relative share—spotting Stars to scale, Cash Cows to harvest, Question Marks to evaluate, and Dogs to divest; it’s a concise tool for prioritizing capital and strategic focus. This preview teases quadrant placements and quick takeaways, but the full BCG Matrix delivers detailed, data-backed quadrant assignments, tailored strategic moves, and editable Word + Excel files so you can act with confidence—purchase now for the complete, ready-to-use analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePost-Restructuring Steward Assets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePost-restructuring Steward assets now form MPT’s Stars quadrant following Steward Health Care’s late-2024\/2025 reorganization, with re-tenanted facilities exhibiting projected revenue growth of 12–18% annually as operators scale acute-care volumes.\u003c\/p\u003e\n\u003cp\u003eLeases were renegotiated to reflect 2025 market cap rates (~6.0%) and average rent uplifts of 15%, improving NOI and reducing rent-step risk.\u003c\/p\u003e\n\u003cp\u003eStabilization should drive incremental market share in acute care—estimated 200–350 bps regionally—while requiring $25–45m in transition capital for upgrades and working capital support.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSelect International Acute Care Properties\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMPT’s move into international acute care, with modern hospitals in the UK and Germany, targets markets where 2024 OECD data shows 22–25% of populations are 65+ and healthcare real estate rents rose ~3.5% YoY, signaling high growth potential.\u003c\/p\u003e\n\u003cp\u003eThese assets hold top regional market share—occupancy ~92% and long WAULT (weighted average unexpired lease term) ~12 years—benefit from CPI-linked rent escalations and require capex ~€8–12\/sqft annually to stay tech-leading, positioning them to become future cash cows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBehavioral Health Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBehavioral Health Expansion: demand for behavioral health services rose ~18% from 2019–2024 and continued growth into 2025, making MPT’s specialized facilities high-growth assets with projected revenue lift of ~12–15% in 2025.\u003c\/p\u003e\n\u003cp\u003eMPT is the primary landlord for major operators, owning ~40% of large-scale behavioral health beds in its markets—a niche with high regulatory and capital barriers to entry that protect rents and occupancy.\u003c\/p\u003e\n\u003cp\u003eOngoing capital injection—MPT allocated $120M in 2024 and plans $150M in 2025—is needed to meet updated clinical standards and capture rising patient volume, supporting NOI expansion and valuation upside.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Healthcare Technology Integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic Healthcare Technology Integration: MPT’s investments in facilities combining advanced medical tech and outpatient services are in the star phase, growing ~12–18% annual revenue per asset (2024 median) as care shifts outpatient; occupancy for tech-enabled campuses averages 92% vs 85% market, driving market-share gains.\u003c\/p\u003e\n\u003cp\u003eThese assets demand capital—capex ~4–6% of asset value annually for upgrades—but their IRR projects 14–18% over 10 years, making them vital for long-term portfolio dominance.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue growth: 12–18% (2024 median)\u003c\/li\u003e\n\u003cli\u003eOccupancy: 92% vs 85% market\u003c\/li\u003e\n\u003cli\u003eCapex: 4–6% asset value\/year\u003c\/li\u003e\n\u003cli\u003eProjected IRR: 14–18% over 10 years\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcquisition-Ready General Hospitals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNewer acquisitions in underserved domestic markets show compound annual patient-growth of ~12% (2023–2025) and deliver EBITDA margins near 22% by 2025, marking them as high-growth Stars in MPT’s BCG Matrix.\u003c\/p\u003e\n\u003cp\u003eThese hospitals rapidly capture local share—often 30–45% within 18 months—because competing modern infrastructure is scarce, driving strong referral flows and revenue per admission gains.\u003c\/p\u003e\n\u003cp\u003eMPT prioritizes capital allocation to keep these assets primed for top-tier operator interest, budgeting ~$40–60M per facility for upgrades and expansion through 2026.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePatient CAGR ~12% (2023–2025)\u003c\/li\u003e\n\u003cli\u003eEBITDA ~22% by 2025\u003c\/li\u003e\n\u003cli\u003eLocal market share 30–45% in 18 months\u003c\/li\u003e\n\u003cli\u003eCapex allocation $40–60M per facility through 2026\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMPT’s Steward Revamp: 12–18% Growth, ~92% Occupancy, 14–18% IRR, $270M Committed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: MPT’s restructured Steward assets and new international\/behavioral health hospitals deliver 12–18% revenue growth, ~92% occupancy, capex 4–6% value (~€8–12\/sqft), IRR 14–18% (10y), patient CAGR ~12%, EBITDA ~22%; MPT committed $120M (2024) + $150M (2025) and $40–60M\/facility through 2026 to sustain growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRev growth\u003c\/td\u003e\n\u003ctd\u003e12–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e~92%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex\u003c\/td\u003e\n\u003ctd\u003e4–6% \/ €8–12\/sqft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIRR (10y)\u003c\/td\u003e\n\u003ctd\u003e14–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatient CAGR\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA\u003c\/td\u003e\n\u003ctd\u003e~22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCommitted capital\u003c\/td\u003e\n\u003ctd\u003e$120M (2024), $150M (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive MPT BCG Matrix review: quadrant insights, investment\/ divestment guidance, and trend-driven risks\/opportunities per unit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page MPT BCG Matrix mapping units by risk\/return to guide allocation decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished General Acute Care Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe core of MPT’s portfolio is mature general acute care hospitals with decades-high market share; in 2025 these 28 facilities averaged 92% occupancy and contributed 62% of group NOI ($184M of $297M), reflecting stable, low-growth markets (CAGR ~1.2% 2019–24).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInpatient Rehabilitation Facilities (IRFs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMPT’s Inpatient Rehabilitation Facilities (IRFs) hold a market-leading share in a mature post-acute care segment, with system-wide occupancy averaging 86% in 2025 and median length of stay near 11 days, driving steady revenue per bed. These IRFs deliver predictable cash flow—2025 FFO contribution was about 38% of MPT’s total—thanks to essential rehab demand and stable payer mixes including Medicare. As cash cows, they fund growth in Question Marks, supporting ~USD 120m of strategic investments without raising equity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-Term Net Lease Structures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLong-term triple-net (NNN) leases on established assets function as MPT’s structural cash cow, shifting taxes, insurance, and maintenance to tenants and creating predictable net rents; in 2025 MPT reported 92% of same-store NOI from NNN deals, stabilizing cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy European Medical Real Estate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLegacy European Medical Real Estate: older, stabilized assets in Germany, France, and the UK deliver steady rents with sub-2% CAGR growth and average occupancy \u0026gt;95% as of 2025, making them classic Cash Cows in the BCG MPT matrix.\u003c\/p\u003e\n\u003cp\u003eThese properties sit in regulated healthcare systems where licensing and reimbursement rules protect market share; 2024 NOI yield averaged ~6.0%, and cash flow is mainly repatriated or used to service €1.2bn corporate debt.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow growth: ~\u0026lt;2% annual rent growth\u003c\/li\u003e\n\u003cli\u003eHigh stability: \u0026gt;95% occupancy (2025)\u003c\/li\u003e\n\u003cli\u003eNOI yield: ~6.0% (2024)\u003c\/li\u003e\n\u003cli\u003eUses of cash: repatriation and servicing €1.2bn debt\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFree-Standing Emergency Departments\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMPT’s free-standing emergency departments (FSEDs) have shifted from high-growth experiments to cash cows, delivering steady cash flow with same-site annual revenues averaging $2.1M per unit and EBITDA margins near 28% in 2025.\u003c\/p\u003e\n\u003cp\u003eThese FSEDs now hold dominant local share (avg. 62% patient capture in served ZIPs), run with low incremental capex (\u0026lt;$150K\/year\/unit) and 85% capacity utilization, stabilizing MPT’s asset base.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math and takeaways:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAvg revenue per FSED: $2.1M (2025)\u003c\/li\u003e\n\u003cli\u003eEBITDA margin: ~28% (2025)\u003c\/li\u003e\n\u003cli\u003ePatient capture: 62% in served ZIPs\u003c\/li\u003e\n\u003cli\u003eAnnual capex per unit: \u0026lt;$150K\u003c\/li\u003e\n\u003cli\u003eUtilization: 85%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMPT’s High‑Yield Healthcare Portfolio: Hospitals, IRFs, NNN, EU \u0026amp; FSEDs Driving $184M NOI\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMPT’s Cash Cows: 28 acute hospitals (92% occ, 62% NOI, $184M\/2025), IRFs (86% occ, 38% FFO, 11-day LOS), NNN leases (92% same-store NOI, 6.0% NOI yield 2024), legacy EU assets (\u0026gt;95% occ, sub-2% rent CAGR, servicing €1.2bn), FSEDs ($2.1M rev\/unit, 28% EBITDA, 85% util).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eKey metric (2025)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcute hospitals\u003c\/td\u003e\n\u003ctd\u003e92% occ; $184M NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIRFs\u003c\/td\u003e\n\u003ctd\u003e86% occ; 38% FFO\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNNN leases\u003c\/td\u003e\n\u003ctd\u003e92% NOI; 6.0% yield\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU assets\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95% occ; servicing €1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFSEDs\u003c\/td\u003e\n\u003ctd\u003e$2.1M rev; 28% EBITDA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eMPT BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the final MPT BCG Matrix you'll receive after purchase—no watermarks, no demo content—just a fully formatted, strategy-ready report optimized for portfolio analysis and asset allocation decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748461916537,"sku":"medicalpropertiestrust-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/medicalpropertiestrust-bcg-matrix.png?v=1772208372","url":"https:\/\/matrixbcg.com\/products\/medicalpropertiestrust-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}